A centralized pharmacy intervention reduces the prior authorization burden on dermatology providers - 22/08/19
Sabrina Popatia, Harvard T. H. Chan School of Public Health, Boston, MA; Baylor College of Medicine, Houston, TX; Suzanne Olbricht, Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Alexa B. Kimball, Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Martina L. Porter, Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 81 - N° 4S1
P. AB5 - octobre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?